Company Fennec Pharmaceuticals Inc. Nasdaq
Equities
CA31447P1009
Biotechnology & Medical Research
Business Summary
Number of employees: 29
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100.0
%
| 2 | 100.0 % | 29 | 100.0 % | +1,335.37% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 29 | 100.0 % | +1,335.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 06/07/09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 06/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 24/04/14 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 31/10/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 24/08/11 |
Khalid Islam
CHM | Chairman | 67 | 24/04/14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 06/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 24/04/14 |
Marco Brughera
BRD | Director/Board Member | 70 | 09/08/16 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 06/07/09 |
Jodi Cook
BRD | Director/Board Member | 56 | 23/09/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,322,141 | 22,935,529 ( 83.94 %) | 0 | 83.94 % |
Company contact information
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |